Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Calderone

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
Biochemical Pharmacology|July 31, 2023
Persulfidation of mitoKv7.4 channels contributes to the cardioprotective effects of the H<sub>2</sub>S-donor Erucin against ischemia/reperfusion injuryL Testai, R Montanaro, L Flori, et al.
Acta Crystallographica. Section D, Biological Crystallography|April 20, 2000
The structure of human aldose reductase bound to the inhibitor IDD384V Calderone, B Chevrier, M Van Zandt, et al.
Pharmacological Research|October 3, 2013
The novel anti-inflammatory agent VA694, endowed with both NO-releasing and COX2-selective inhibiting properties, exhibits NO-mediated positive effects on blood pressure, coronary flow and endothelium in an experimental model of hypertension and endothelial dysfunctionA Martelli, L Testai, M Anzini, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
Biochemical Pharmacology|July 31, 2023
Persulfidation of mitoKv7.4 channels contributes to the cardioprotective effects of the H<sub>2</sub>S-donor Erucin against ischemia/reperfusion injuryL Testai, R Montanaro, L Flori, et al.
Acta Crystallographica. Section D, Biological Crystallography|April 20, 2000
The structure of human aldose reductase bound to the inhibitor IDD384V Calderone, B Chevrier, M Van Zandt, et al.
Pharmacological Research|October 3, 2013
The novel anti-inflammatory agent VA694, endowed with both NO-releasing and COX2-selective inhibiting properties, exhibits NO-mediated positive effects on blood pressure, coronary flow and endothelium in an experimental model of hypertension and endothelial dysfunctionA Martelli, L Testai, M Anzini, et al.
Pageof 5